Mass spectrometer parameters for FMO substrates
| Analyte | MRM (Parent→Daughter) m/z | Dwell | Cone Voltage | Collision Energy |
|---|---|---|---|---|
| s | V | |||
| Tamoxifen | 372.166→129.175 | 0.080 | 10 | 25 |
| Moclobemide | 269.053→182.073 | 0.080 | 10 | 15 |
| Olanzapine | 313.127→84.118 | 0.080 | 10 | 25 |
| Imipramine | 281.178→86.025 | 0.080 | 60 | 15 |
| Tozasertib | 465.195→190.215 | 0.080 | 20 | 40 |
| Ranitidine | 315.095→176.243 | 0.040 | 10 | 15 |
| Benzydamine | 310.173→86.065 | 0.080 | 60 | 30 |
| Cimetidine | 253.06→94.994 | 0.080 | 20 | 20 |
| Clozapine | 327.14→270.16 | 0.080 | 40 | 20 |
| Itopride | 359.22→71.94 | 0.80 | 10 | 40 |
| Verapamil (IS) | 455.198→165.207 | 0.020 | 15 | 25 |